Krystal Biotech, Inc. Common Stock (KRYS)

Health Care·equity

$331.61

+1.32% today

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

57/ 100

Score level

Above average

6 of 6 checks had data

Smart-money score is on the low side — how it compares with the broader market is one of its highest-scoring factors, while business numbers score (revenue, margins, returns) is near the top of its range.

KRYS scores higher than 81% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Krystal Biotech, Inc. Common Stock (KRYS) scores 57 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.71× 30-day average
52-week range: 179.19 – 382.54
Market cap: $9.97B
Earnings date: 2 Nov 2026

Volume: 196,947
Avg. volume (30d): 278,150

Open: 326.55
Previous close: 327.30
Day's range (regular session): 323.87 – 333.56

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 0.64
P/E (TTM): 40.65
EPS (TTM): 7.98

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for KRYS

35 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for KRYS. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about KRYS right now

Krystal Biotech, Inc. Common Stock (KRYS) currently scores 57/100 on the Market Census six-factor composite, at the Above average score level. KRYS is +1.32% on the day and +2.78% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for KRYS leans good, with some weak spots. KRYS's strongest factor is strength vs the market at 79/100 — a strong read on how KRYS has done next to the wider market. It describes what has happened, not what happens next. The weakest factor is insider trades at 10/100 — a well below average read on insider buying and selling. Insider filings for KRYS lean toward selling; on a thinly filed name a few filings can set this reading.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See KRYS in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score